Analysis: What’s the next blockbuster after Lipitor?
With the launch of an authorized generic, Lipitor — the medication that defined the term mega-blockbuster — has now lost patent protection. Astutely managed chain pharmacy organizations have calculated the effect on sales and margins going forward.